ED, Targeting & Field Intelligence
Novartis
Summary
The ED, Targeting and Field Intelligence leads the enterprise Targeting & Field Intelligence organization responsible for translating brand strategies, customer priorities, and business objectives into actionable field intelligence models, targeting approaches, and decision-support capabilities that improve customer engagement and commercial effectiveness.
Job description
Job Description Summary
The ED, Targeting and Field Intelligence leads the enterprise Targeting & Field Intelligence organization responsible for translating brand strategies, customer priorities, and business objectives into actionable field intelligence models, targeting approaches, and decision-support capabilities that improve customer engagement and commercial effectiveness.
Partner with Brand and Customer Insights & Analytics leaders, who retain ownership of business and customer strategy, to convert strategic priorities into clear field intelligence frameworks, recommendations, and actions. Lead the capability roadmap, governance, methodologies, and operating model for targeting, field decision intelligence, and Next Best Action enablement across therapeutic areas.
Key Responsibilities
The Executive Director is the enterprise capability leader accountable for:
- Customer and account targeting methodologies and models
- Field decision intelligence, prioritization, and action-planning frameworks
- Next Best Action strategy and analytical enablement
- Opportunity identification and intelligence-to-action models
- Field intelligence products, standards, governance, and reusable assets
- Targeting and field intelligence capability roadmaps and investment priorities
- Define and lead the enterprise strategy, roadmap, and operating model for targeting, field intelligence, Next Best Action, and field decisioning capabilities aligned to business growth priorities.
- Partner with Brand, Commercial Insights & Analytics, and business leaders to translate strategic objectives into scalable intelligence-driven field execution models.
- Govern enterprise-wide targeting, prioritization, and decision intelligence methodologies across therapeutic areas to drive consistent, data-driven customer engagement.
- Lead the integration of customer, patient, market, performance, and predictive analytics into actionable recommendations that improve field effectiveness and business outcomes.
- Advance AI-enabled decisioning, recommendation engines, and intelligence-to-action solutions while ensuring compliance, governance, and responsible AI practices.
- Drive continuous improvement in the relevance, adoption, usability, and measurable impact of targeting and field intelligence capabilities.
- Partner with Field Design & Deployment leaders to ensure intelligence-driven recommendations inform territory design, resource allocation, and execution strategies.
- Collaborate with Strategy, Platforms & Technology (SPT) to shape product roadmaps, define business requirements, and accelerate adoption of field intelligence and decision-support solutions.
- Build strong partnerships across Hyderabad (HYD), Advanced Analytics, Customer & Patient Intelligence, Medical, Market Access, and Commercial organizations to deliver scalable, high-quality capabilities.
- Lead, develop, and inspire a high-performing team of Targeting & Field Intelligence leaders, fostering innovation, accountability, talent development, succession planning, and continuous learning across global teams.
Essential Requirements
- Advanced degree in Business Administration, Data Science, Analytics, or a related field
- Minimum 10+ years of experience, biotechnology, healthcare, or another complex regulated industry
- Demonstrated expertise in targeting, field intelligence, commercial analytics, decision intelligence, Next Best Action, or customer analytics
- Previous experience leading Directors and Associate Director
- Ability to translate commercial strategy into scalable analytical models, governance, and decision-support capabilities
- Experience leading cross-functional, global, and matrixed organizations and influencing senior stakeholders
- Working knowledge of AI-enabled analytics, automation, data products, privacy, compliance, and responsible AI practices
Desirable Requirements
- Portfolio Management Experience preferred
Requirements
- Advanced degree in Business Administration, Data Science, Analytics, or a related field
- Minimum 10+ years of experience in biotechnology, healthcare, or another complex regulated industry
- Demonstrated expertise in targeting, field intelligence, commercial analytics, decision intelligence, Next Best Action, or customer analytics
- Previous experience leading Directors and Associate Directors
- Ability to translate commercial strategy into scalable analytical models, governance, and decision-support capabilities
- Experience leading cross-functional, global, and matrixed organizations and influencing senior stakeholders
- Working knowledge of AI-enabled analytics, automation, data products, privacy, compliance, and responsible AI practices
- Portfolio Management experience preferred
Benefits
- Health Insurance
- Life Insurance
- Disability Benefits
- 401(k) Matching
- Generous Time Off
- Vacation
- Personal Days
- Holidays
- Performance-Based Cash Incentive
- Annual Equity Awards
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.